Naveed Saqib, MD
Vascular Surgery · Pasadena, TXNPI 1033258041
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (45.0%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Medtronic accounts for 62.5% of it on its own, with 42 other manufacturers making up the rest. Reporting peaked in 2024 at $15,365 and has fallen 81.1% since, to $2,899 in 2025.
Across 443 payments — averaging $95.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$27K
- Cook Medical LLC$5K
- W. L. Gore & Associates, Inc.$4K
- Silk Road Medical, Inc.$1K
- Endologix LLC$1K
- Inari Medical, Inc.$457
- plus $3K from 37 others
Across 31 payments — averaging $3088.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Silk Road Medical, Inc.$58K
- W. L. Gore & Associates, Inc.$27K
- Boston Scientific$8K
- Cook Research Incorporated$3K
What the payments were for
- Consulting fees$8752%
- Speaking & faculty fees$5,60013%
- Travel & lodging$16,81040%
- Food & beverage$19,10445%
- Education$380%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HawkOne$17,530
- Zenith Alpha$2,745
- IN.PACT Admiral$2,684
- EXCLUDER Iliac Branch Endoprosthesis$1,160
- ENROUTE Transcarotid Neuroprotection System$908
- ENROUTE Transcarotid Stent$754
- Alto Abdominal Stent Graft System$587
- GORE TAG Thoracic Branch Endoprosthesis$555
- Endurant$493
- TurboHawk$465
- Cook$391
- GORE EXCLUDER AAA Endoprosthesis$365
- Valiant Captivia$353
- Zilver PTX$294
- Zenith$290
- ENDURANT IIS$283
- FlowTriever$277
- ClotTriever$277
- AFX2 Bifurcated Endograft System$243
- Torus Stent Graft System$220
How this compares
$42,427 in reported general payments places this provider in the 85th percentile of 347 vascular surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 222 | $2,569 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 126 | $1,097 |
| Prednisone | 29 | $41 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Pasadena
- Gregory PearlDallas$2.3M
- Mazin FotehAustin$1.6M
- Alan LumsdenHouston$742K
- Stephen HohmannDallas$499K
- Michael SiahDallas$392K
- Gustavo OderichHouston$319K
- Jean BismuthHouston$243K
- Carlos TimaranDallas$231K
- Dennis GableDallas$211K
- Thomas LohShenandoah$201K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.